Clinical Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

About the Cover

Cover Figure


Mice bearing orthotopic ovarian carcinoma were treated with FAK siRNA in DOPC liposomes with or without docetaxel. The cover figure shows immunofluorescence dual-localization (yellow) of endothelial cells (red) and apoptotic cells (green) in sections obtained from mice treated with combination therapy. The greatest increase in endothelial cell apoptosis was observed following treatment with combination of FAK siRNA-DOPC and docetaxel. For further details, see Halder et al. on page 4916 in this issue.

[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.